GlassScriptPhysician profile
Michael Walter Ball
NPI 1396719761
$76,286.96
in general payments reported to CMS, 2019-2025
30 companies · $1,762 in 2025
The $1,762 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $12K · 2021: $13K · 2022: $18K · 2023: $1,736 · 2024: $1,642 · 2025: $1,762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,840 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,839.86 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $57,797.87 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $7,851.20 | 2019-2025 | Brilinta, Farxiga |
| Medtronic Vascular, INC. | $4,154.35 | 2019-2020 | |
| Abbott Laboratories | $1,225.14 | 2019-2025 | Dragonfly Opstar, Diamondback Coronary, Mitraclip |
| Shockwave Medical, INC | $736.99 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $661.49 | 2019-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $578.53 | 2019-2025 | Watchman Access System, Avvigo Guidance System, Watchman Flx |
| Biotronik INC. | $493.72 | 2019-2024 | Orsiro Mission, Pk Papyrus, Nhancer Rx |
| Novartis Pharmaceuticals Corporation | $396.12 | 2019-2025 | |
| Pfizer INC. | $305.01 | 2020-2025 | |
| Abiomed | $279.78 | 2024-2025 | Impella |
| Philips North America LLC | $216.51 | 2019-2022 | |
| Amgen INC. | $212.33 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $202.57 | 2025 | Onyx Frontier |
| Asahi Intecc USA, INC. | $199.61 | 2025 | Asahi Coronary Wires |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $181.12 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $177.37 | 2022-2025 | Jardiance |
| Livanova USA, INC. | $142.57 | 2022 | |
| Esperion Therapeutics, INC. | $98.65 | 2024-2025 | Nexletol |
| Alnylam Pharmaceuticals INC. | $80.42 | 2024 | Onpattro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $66.26 | 2024 | Lifevest |
| Kiniksa Pharmaceuticals International, Plc | $46.27 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $38.88 | 2024 | |
| Amarin Pharma, INC. | $36.86 | 2021-2022 | |
| Novo Nordisk INC | $24.52 | 2025 | Ozempic |
| Inspire Medical Systems, INC. | $21.73 | 2025 | Inspire |
| Kiniksa Pharmaceuticals, LTD. | $19.37 | 2023 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $15.06 | 2019 | |
| Mannkind Corporation | $14.53 | 2025 | |
| Gilead Sciences, INC. | $12.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ball listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.